Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    17405999 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Celecoxib to Prevent Cancer in Patients With Barrett's Esophagus
Condition: Esophageal Cancer
Intervention: Drug: celecoxib

Indicates status has not been verified in more than two years